231 related articles for article (PubMed ID: 15918066)
1. [Bisphosphonates and osteonecrosis of the jaw].
Schirmer I; Peters H; Reichart PA; Dürkop H
Mund Kiefer Gesichtschir; 2005 Jul; 9(4):239-45. PubMed ID: 15918066
[TBL] [Abstract][Full Text] [Related]
2. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
Friedrich RE; Blake FA
Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
[TBL] [Abstract][Full Text] [Related]
3. [A case of osteonecrosis of the lower jaw due to bisphosphonates in a breast cancer patient with bone metastasis].
Kubo N; Katayama K; Ishizaki A; Morinaga N; Negishi T; Kuwano H
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1973-5. PubMed ID: 19011355
[TBL] [Abstract][Full Text] [Related]
4. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
5. [Osteonecrosis of the jaws by long term therapy with bisphosphonates].
Piesold JU; Al-Nawas B; Grötz KA
Mund Kiefer Gesichtschir; 2006 Sep; 10(5):287-300. PubMed ID: 16960697
[TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition.
Melo MD; Obeid G
J Am Dent Assoc; 2005 Dec; 136(12):1675-81. PubMed ID: 16383049
[TBL] [Abstract][Full Text] [Related]
7. Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.
Van Poznak C; Estilo C
Oncology (Williston Park); 2006 Aug; 20(9):1053-62; discussion 1065-6. PubMed ID: 16986349
[TBL] [Abstract][Full Text] [Related]
8. Jaw osteonecrosis in patients treated with bisphosphonates: an ultrastructural study.
Perrotta I; Cristofaro MG; Amantea M; Russo E; De Fazio S; Zuccalà V; Conforti F; Amorosi A; Donato G; Tripepi S; Giudice M
Ultrastruct Pathol; 2010 Aug; 34(4):207-13. PubMed ID: 20594040
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment.
Fehm T; Felsenberg D; Krimmel M; Solomayer E; Wallwiener D; Hadjii P
Breast; 2009 Aug; 18(4):213-7. PubMed ID: 19651512
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
11. Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.
Wutzl A; Eisenmenger G; Hoffmann M; Czerny C; Moser D; Pietschmann P; Ewers R; Baumann A
Wien Klin Wochenschr; 2006 Aug; 118(15-16):473-8. PubMed ID: 16957978
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate (zoledronic acid)-induced osteonecrosis of the jaw.
Haidar A; Jønler M; Folkmar TB; Lund L
Scand J Urol Nephrol; 2009; 43(6):442-4. PubMed ID: 19903091
[TBL] [Abstract][Full Text] [Related]
13. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer.
Bianchi SD; Scoletta M; Cassione FB; Migliaretti G; Mozzati M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):249-58. PubMed ID: 17560140
[TBL] [Abstract][Full Text] [Related]
14. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
[TBL] [Abstract][Full Text] [Related]
15. Jaw osteonecrosis associated with use of bisphosphonates and chemotherapy: paradoxical complication of treatment of bone lesions in multiple myeloma patients.
Capalbo S; Delia M; Diomede D; Dargenio M; Chiefa A; Favia G; Liso V
Int J Hematol; 2006 Jun; 83(5):439-42. PubMed ID: 16787865
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-induced osteonecrosis of the jaw.
Krueger CD; West PM; Sargent M; Lodolce AE; Pickard AS
Ann Pharmacother; 2007 Feb; 41(2):276-84. PubMed ID: 17299010
[TBL] [Abstract][Full Text] [Related]
17. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.
Hansen T; Kunkel M; Weber A; James Kirkpatrick C
J Oral Pathol Med; 2006 Mar; 35(3):155-60. PubMed ID: 16454811
[TBL] [Abstract][Full Text] [Related]
18. Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases.
Junquera L; Gallego L; Cuesta P; Pelaz A; de Vicente JC
Am J Otolaryngol; 2009; 30(6):390-5. PubMed ID: 19880027
[TBL] [Abstract][Full Text] [Related]
19. [Bisphosphonate-associated osteonecrosis of the jaw].
Abu-Id MH; Açil Y; Gottschalk J; Kreusch T
Mund Kiefer Gesichtschir; 2006 Mar; 10(2):73-81. PubMed ID: 16456688
[TBL] [Abstract][Full Text] [Related]
20. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
Farrugia MC; Summerlin DJ; Krowiak E; Huntley T; Freeman S; Borrowdale R; Tomich C
Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
